Randomized, Double bind, Two arm, Multicentric, Comparative Controlled, Prospective Clinical trial of Mycobacterium w in combination with satandard therapy versus standard therapy alone in sepsis due to gram (-) ve infections.

Trial Profile

Randomized, Double bind, Two arm, Multicentric, Comparative Controlled, Prospective Clinical trial of Mycobacterium w in combination with satandard therapy versus standard therapy alone in sepsis due to gram (-) ve infections.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Cadi 05 (Primary) ; Aminoglycosides; Cephalosporins; Imipenem; Meropenem
  • Indications Gram-negative infections; Sepsis; Septic shock
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 01 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top